Re.Mind

re.Mind is a venture capital fund dedicated to mental and neurological health. Subversive has been a limited partner (LP) since 2021. re.Mind focuses on investing in companies that are developing innovative solutions to improve mental health and wellness, with a focus on brain-computer interfaces (BCIs), personalization, new pharmacology, and new modalities. 

Some of the companies that re.Mind has invested in include Synchron, Tripp, Neumora, Sensorium, Blackrock Neurotech, and others. Many of these companies are also under Subversive Capital's portfolio, as we both share a commitment to supporting companies that are working to address the mental health crisis.